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A B S T R A C T
Far-flung evolution in tissue engineering enabled the development of bioactive and biodegradable materials to
generate biocomposite nanofibrous scaffolds for bone repair and replacement therapies. Polymeric bioactive
nanofibers are to biomimic the native extracellular matrix (ECM), delivering tremendous regenerative potentials
for drug delivery and tissue engineering applications. It's been known from few decades that Zinc oxide (ZnO)
nanoparticles are enhancing bone growth and providing proliferation of osteoblasts when incorporated with
hydroxyapatite (HAp). We attempted to investigate the interaction between the human foetal osteoblasts (hFOB)
with ZnO doped HAp incorporated biocomposite poly(L-lactic acid)-co-poly(ε-caprolactone) and silk fibroin
(PLACL/SF) nanofibrous scaffolds for osteoblasts mineralization in bone tissue regeneration. The present study,
we doped ZnO with HAp (ZnO(HAp) using the sol-gel ethanol condensation technique. The properties of PLACL/
SF/ZnO(HAp) biocomposite nanofibrous scaffolds enhanced with doped and blended ZnO/HAp were char-
acterized using Scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), Contact
angle and Tensile studies to determine the morphology, functionality, wettability and stability. The in vitro study
results showed that the addition of ZnO and HAp enhances the secretion of bone mineral matrix (98%) with
smaller fiber diameter (139.4 ± 27 nm) due to the presence of silk fibroin showing potential tensile properties
(322.4%), and increased the proliferation of osteoblasts for bone tissue regeneration.
1. Introduction
Strategy to repair and regenerate bones using the best combination
of biomaterials with biodegradable polymers in bone tissue en-
gineering. Maintain the existing bone tissue structure or to enable bone
tissue growth, bone tissue engineering is one such aspect that utilizes
both engineering and life science disciplines. Orthopaedic implants
such as titanium and its alloys have an average functional regenerative
lifespan of 10–15 years. Surface modification for metal implants are
required to support the bone growth [1]. Detrimental wear debris as
well as stress and strain imbalance at the tissue-implant interface,
leading to loosening of the implant and inevitable failure due to poor
integration of orthopaedic implants [2]. Recently, bone tissue en-
gineering focused on the development of 3D scaffolds, which requires
higher stability and biocompatibility. These scaffolds should fulfil the
requirements such as interconnected microporous structure to support
the cells and exchange of nutrients. The absorption kinetics, mechanical
strength and adequate surface area of the scaffolds are also important
for cell viability and scaffold durability [3,4]. Generally used polymers
for tissue engineering applications such as polycaprolactone (PCL) [5],
poly(lactide) [6], poly(glycolide) [6,7], poly(lactide-co-glycolide) [8],
poly-L-lactic acid (PLLA) [9], polyorthoesters [10], poly(L-lactic acid)-
co-poly(ε-caprolactone) (PLACL) [11], polyphospoesters, poly-
anhydrides, polyphosphazanes and polyethylene oxide.
PLACL is an elastomeric copolymer of PCL and PLLA was found to
be potential synthetic biopolymer to fabricate nanofibers for bone
tissue regeneration therapy [11] satisfies the material properties like
high surface to volume ratio, osteoconductive, osteoinductive, non-
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cytotoxicity, interconnectivity of pores for neovascularization at the site
of new tissue regeneration, sufficient porosity for the transport of nu-
trients and regulatory factors [12]. Silk fibroin (SF), is a provisional
matrix due to its importance in the early stages of wound healing, bone
repair and for their excellent bioactive properties. SF is functional
biomaterial with high elasticity, significant crystallinity, strength, re-
sistance and toughness. Apart from being one of the important natural
polymers for the better tensile strength of SF shows additional effects
like good water vapour and oxygen permeability, slow degradation
rate, minimal inflammatory response and ability to use in several forms
with high endurance [13]. The nanoparticle allows their internalization
into cells in greater extent and allows them to interact with biomole-
cules within or on the cell surface, enabling them to potentially affect
cellular function in a dynamic and selective manner. There are many
different metal and metal oxide nanoparticles like MgO [14,15], Ag
[16], Fe2O3 [17], TiO2 [18], CuO [19], Mg(OH)2 [20] and ZnO [21,22]
are used for various biomedical and biotechnology applications. Among
which, zinc oxide nanoparticles (NPs) stand aside by showing its
maximum antibacterial activity and excellent biocompatibility [21,22].
Recent studies have indicated that ZnO nanoparticles affected functions
of different cells or tissues, biocompatibility and neural tissue en-
gineering [23–25]. ZnO particles are currently listed as a ‘Generally
Recognized as Safe (GRAS)’ material by the Food and Drug Adminis-
tration and also used as a food additive and in many products.
Hydroxyapatite is highly biocompatible, biodegradable and has a
greater identity with the inorganic component of vertebrate bone [26].
Recently, HAp has been used for numerous biomedical applications,
including matrices for controlled drug delivery in bone tissue en-
gineering [27]. HAp is generally doped with different trace elements to
increase it's biological activity. Zinc being highly used metal oxide in
medicines and having an important trace element in biological tissues,
shows the activity of> 300 types of enzymes [28] are suitable for bone
tissue engineering. Zinc-doped hydroxyapatite nanoparticles (ZnO/
HAp) are biocompatible, have increased bioactivity, nucleic acid me-
tabolism, enzyme activity and biomineralization [29]. Several studies
have reported that the amount of zinc incorporates with HAp tend to
show greater bone healing properties [30] despite the incorporation of
zinc into HAp is based on the method and condition used for synthesis
[31–33]. Recently, researchers found zinc ions are essential for various
metabolic activities in most of the living organisms also shows the sti-
mulatory effect on bone formation in vitro and in vivo [34]. The ob-
jective of this research is to synthesise ZnO nanoparticle doped with
HAp along with PLACL/silk fibroin in a controlled environment and
discussed the interaction with osteoblasts and its ability to enhance the
secretion of ECM for mineralization in bone tissue regeneration.
2. Materials and methods
Human foetal osteoblast cells (hFOB) were obtained from American
Type Culture Collection (ATCC, Arlington, VA). Antibiotics, foetal bo-
vine serum (FBS), Dulbecco's Modified Eagle's Medium/Nutrient
Mixture F-12 (HAM), trypsin-EDTA, polyvinylpyrrolidone (PVP), zinc
acetate, absolute ethanol, 1,1,1,3,3,3-hexafluoro-2-propanol (HFP) and
hexamethyl-disilazane (HMDS) were purchased from Sigma, Singapore.
Poly(L-lactic acid)-co-poly-ε-caprolactone (Mw 150 kDa) (70:30) was
obtained from Boehringer Ingelheim Pharma, GmbH & Co., Ingelheim,
Germany. CellTiter 96 AQueous One solution was purchased from
Promega, Madison, WI, USA. Crystalline hydroxyapatite (Microwave
method) and zinc oxide nanoparticles were synthesised in NUS-CNN,
Singapore.
2.1. Synthesis of nanoparticles
2.1.1. Synthesis of zinc oxide nanoparticles
Zinc oxide nanoparticles were synthesised using ethanol condensa-
tion sol-gel process. To prepare ZnO nanoparticles, zinc acetate (5mM)
dissolved in 90ml absolute ethanol for 15–20min under low tem-
perature (30 °C) in glycerol bath to provide localized uniform heating.
Meanwhile, dissolve 0.90 g of PVP (Mw 150 kDa) in 10ml of deionized
water. After PVP dissolved completely then add the solution to zinc
acetate ethanol mixture drop-wise and continue stirring for 1 h. After
1 h stirring use water condensation and stir overnight. Collect the
sample and heat treat at 100 °C for 2 h followed by calcination at
300 °C.
2.1.2. Synthesis of zinc oxide doped hydroxyapatite
Synthesis of zinc oxide doped hydroxyapatite (ZnO/HAp), 5mM
zinc acetate was dissolved in 90ml absolute ethanol for 15min under
continuous stirring. Add 0.45 g HAp and continue stirring for another
30min. Dissolve 0.90 g of PVP in 20ml of deionized water. Add PVP
solution dropwise into the precursor solution and stir with minimum
rpm at 90 °C for 24 h under ethanol condensation system. After 24 h
collected the samples and dry at 50 °C for 2 h then anneal at 120 °C for
8 h.
2.2. Fabrication of nanofibrous scaffolds
Electrospinning of prescribed nanofibers requires the optimisation
of various parameters including voltage, flow rate, distance between
the tip and substrate, viscosity of the solution, homogeneity of the so-
lution. PLACL was dissolved in HFP to obtain 15% wt. solution and
electrospun at a voltage of 13.5 kV at a stipulated distance of 10–13 cm.
PLACL and synthesised zinc oxide nanoparticles mixed in HFP solvent
with a weight percent of 14% and 1% respectively. Similarly, PLACL,
silk fibroin and zinc oxide particles were dissolved in HFP at 13:1:2, all
these solvents are kept stirring overnight to form a uniform homo-
geneous solution without lumps and air bubbles. The samples PLACL/
SF/ZnO/HAp and PLACL/SF/ZnO(HAp) are prepared in the ratio of
12:1:1:1 and 12:1:2 respectively and left stirring overnight. The final
concentration of all the polymer blends kept constant at 15%. The de-
tails of electrospun fibers and their solution parameters are given in
Table 1. The fabricated nanofibers are kept at an ambient temperature
of 22–25 °C and relative humidity of 40–60%.
2.3. Characterization of nanofibrous scaffolds
Morphological studies of PLACL, PLACL/ZnO, PLACL/SF/ZnO,
PLACL/SF/ZnO/HAp and PLACL/SF/ZnO(HAp) electrospun bio-
composite nanofibers were analysed using Field Emission Scanning
Electron Microscope (JEOL JSM 6700, Japan) at an acceleration voltage
of 10 kV, after sputter coating with gold (JEOL JFC-1200 Fine Coater,
Japan). Structural analyses performed with SEM images, using image
Table 1
Electrospinning parameters for the fabrication of nanofibers.
S/No Samples Concentration (%) Voltage (kV) Flow rate (ml/h) Needle size Fiber diameter (nm)
1 PLACL 15 13.5 1.5 22G 627.3 ± 103
2 PLACL/ZnO 14:1 13 1 22G 715.4 ± 190
4 PLACL/SF/ZnO 13:1:2 13.5 1 23G 192 ± 69
5 PLACL/SF/ZnO/HAp 12:1:1:1 15 1 23G 156.6 ± 53
6 PLACL/SF/ZnO(HAp) 12:1:2 15 1 23G 139.4 ± 27
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analysis software (ImageJ, National Institutes of Health, USA). An
average of n=6 images was taken from each sample with n=60 na-
nofibers were chosen from each image for determining the diameter of
nanofibers in each sample with mean and standard deviation. Table top
tensile tester (Instron 3345, USA) is used to determine the mechanical
properties of electrospun biocomposite nanofibrous scaffolds with load
cell of 10N capacity and intense pressure control capacity. The scaffolds
were made into 10×30 mm dimension with thickness over
200–250 μm. The samples were mounted vertically into the mechanical
gripping units of the Instron. Obtained results were calculated and re-
corded for every 50ms over a crosshead speed of 5mm/min at room
temperature and controlled humidity. For each scaffold, n=6 samples
are prepared and tested. The built-in automated software (Blue Hill
Materials Testing Software, Instron, USA) calculates the tensile
Fig. 1. Chemical structure of zinc incorporated hydroxyapatite.
Fig. 2. SEM images for biocomposite nanofibrous scaffolds. (a) PLACL, (b) PLACL/ZnO, (c) PLACL/SF/ZnO, (d) PLACL/SF/ZnO/HAp, (e) PLACL/SF/ZnO(HAp).
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properties such as resistance to deformation at the breaking point with
the given stress and strain and load bearing capacity. Chemical and
functional bonding of the samples were studied using Fourier transform
infrared spectroscopy (FTIR-Avatar 380, Thermo Nicolet, Waltham,
MA,USA) over the range of 400–4000 cm−1. Wettability of the nano-
fibrous scaffolds was analysed using the video contact angle (VCA)
Optima surface analysis system (AST Product, Billerica, MA). The hy-
drophobic samples were treated with radiofrequency glow discharge
chamber (PDC-001, Harrick scientific Corporation, USA). Plasma 30W
RF was made contact for 15–30 s to convert the hydrophobic surface
into hydrophilic nanofibrous scaffolds.
2.4. Culture of hFOB
Osteoblasts (hFOB) used to study the biocompatibility of electro-
spun nanofibrous scaffolds. The cells were cultured in DMEM/F12
medium (1:1) containing 10% FBS and 1% antibiotic and antimycotic
solutions in a 75 cm2 cell culture flask. The cells were incubated at 37 °C
with intense humidity containing 5% CO2 and sporadic change of fresh
culture medium for every 2–3 days. The nanofibers were sterilized by
treating ultraviolet light (UV) for 3 h. The sterilized fibers placed in 24
well plate with stainless-steel rings, in order to avoid lifting of fibers
upwards followed by washing by PBS to remove the residual solvents
consequently; the fibers were then kept overnight in DMEM/F12
medium before seeding cells. The confluent osteoblast cultures were
trypsinized by adding 1ml of 0.25% trypsin containing 0.1% EDTA.
Trypsinized cells were centrifuged, counted by Trypan blue assay using
haemocytometer. The counted cells were then seeded on TCP (control),
PLACL, PLACL/ZnO, PLACL/SF/ZnO, PLACL/SF/ZnO/HAp and
PLACL/SF/ZnO(HAp) nanofibrous scaffolds at the density of 1× 104
cells per well and kept in incubator to facilitate the uninterrupted
growth of cells.
2.5. hFOB proliferation
hFOB proliferation on electrospun nanofibrous scaffolds were
monitored on 5, 10 and 15 days after seeding the cells. Cell prolifera-
tion was quantified using MTS assay (3-(4,5-dimethylthiazol-2-yl)-5-(3-
caboxymethoxphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) by Cell Titer
96® AQueous One Solution (Promega, Madison, WI, USA). The reduction
of yellow tetrazolium salts by dehydrogenase enzymes secreted by
metabolically active cells break down to form purple formazan crystals.
The process of MTS assay is carried out by washing with PBS to remove
dead cells and incubated with 20% MTS reagent in a serum free
medium for 3 h at 37 °C. The amount of formazan crystal formed varies
proportionally with the number of cells. Then the samples were ana-
lysed at the absorbance range of 492 nm using FLUO star OPTIMA
Spectrometric plate reader (BMG Lab Technologies).
2.6. Alkaline phosphatase activity
Alkaline phosphatase yellow liquid substrate system (Sigma Life
Science, USA) was used to analyse the bone-forming ability of hFOB
seeded on the biocomposite nanofibrous scaffolds. The cells were cul-
tured for 5, 10 and 15 days and periodically subjected to ALP activity
on the stipulated time periods. After washed twice with phosphate
buffer saline, ALP substrate solution was added to each well and in-
cubated for an hour, then the reaction was stopped using 2 N NaOH.
Then the yellow colour developed solution from each well was trans-
ferred to 96 well plates and observed using spectrophotometric
Microplate reader at an absorbance of 405 nm.
2.7. Staining of Alizarin Red-S
Mineralization of hFOB was quantified and monitored by Alizarin
Red-S (ARS) staining. ARS binds to calcium salts selectively to consider
the most widely used calcium mineral histochemistry (calcium che-
lating product). The cells scaffolds were washed twice with PBS and
fixed with 70% ice-cold ethanol for an hour. After fixing with ethanol,
the scaffolds were washed thrice with deionized water and stained with
40mM ARS for 30–60min at room temperature. Then washed with DI
water to remove excess stains then captured the images under an op-
tical microscope using image analysis software (Leica FW4000, version
v 1.0.2). After a constant wash with deionized water, the scaffolds were
desorbed using 10% cetylpyridinium chloride and incubate for 1 h. The
dye was collected and absorbance is measured at 540–570 nm using
spectrophotometer (Thermo Spectronic, Waltham, USA).
2.8. Mineralization of osteoblasts
Nanofibrous scaffolds after 9 days of the culture period, the osteo-
blasts cultured nanofibrous scaffolds were gently washed with PBS to
remove dead cells and then fixed in 3% glutaraldehyde for 3 h at room
temperature. Thereafter, the scaffolds were rinsed with distilled water
Table 2
Contact angles measurements for nanofibrous scaffolds.






Fig. 3. Tensile properties of PLACL, PLACL/ZnO, PLACL/SF/ZnO, PLACL/SF/
ZnO/HAp, PLACL/SF/ZnO(HAp) nanofibrous scaffolds.
Table 3
Tensile properties of the nanofibrous scaffolds.
Sample/properties PLACL PLACL/ZnO PLACL/SF/ZnO PLACL/SF/ZnO/HAp PLACL/SF/ZnO(HAp)
Ultimate Stress (MPa) 1.27 ± 0.15 2.25 ± 0.10 2.56 ± 0.15 0.84 ± 0.25 1.10 ± 0.20
Ultimate Strain (%) 254.00 322.4 98.2 84.3 56.4
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and increasing the concentration of alcohol (50%, 70%, 90%, and
100%) twice with a time interval. Subsequently, the samples were
added HMDS and allowed to air dry overnight in a fume hood. Then the
samples were subjected to gold sputtering and observed under FESEM
for the mineralization of osteoblasts.
2.9. Cell tracking using 5-chloromethylfluorescein diacetate
Multigenerational tracking of live cells monitored using the CMFDA
fluorescent dye (5-chloromethylfluorescein diacetate). The cells-scaf-
folds were treated with CMFDA dye on day 15 and observed the mor-
phology of live cells. The cells were incubated with dye after removal of
medium and washed with PBS. Before adding 20 μl of CMFDA (25 μM)
and 180 μl of DMEM is added to each wells and incubated for 2 h at
37 °C in 5% CO2 atmosphere. After incubation, CMFDA dye was dis-
carded and washed with PBS then by adding 1ml of medium supple-
mented with 10% FBS and incubated overnight. The cells were washed
twice with PBS after overnight incubation subsequently serum free
medium was added and observed under inverted Leica DM IRB laser
scanning microscope (Leica DC 300F) at 488 nm.
2.10. Statistical analysis
Experiments were conducted 6 times and all the data presented
were expressed as mean ± standard deviation (SD). Statistical analysis
was plotted using Student's t-test; P≤0.001 was considered to be
highly significant.
3. Results and discussion
3.1. Interaction of zinc and hydroxyapatite
Interactions of zinc and hydroxyapatite in order to establish the
influence of Zn on the properties of the obtained materials [35]. Zinc
being the best promoter of bone growth [36], inhibits bone resorption
[37], offers antimicrobial residents to implants [38] and unmatched
potential form imparting multifunctional abilities in bone therapies.
The incorporation of zinc helps in maintaining the pH in simulating
body fluid (SBF) within physiological limits. Antibacterial activity of Zn
doped hydroxyapatite was investigated by Stanić et al. providing the
activities of biocomposite ZnO-HAp [39]. Zhou et al. reported the
Fig. 4. FTIR spectra of biocomposite nanofibrous scaffolds. (a) PLACL, (b) PLACL/ZnO, (c) PLACL/SF/ZnO, (d) PLACL/SF/ZnO/HAp, (e) PLACL/SF/ZnO(HAp).
Fig. 5. Proliferation of hFOB cultured on TCP, PLACL, PLACL/ZnO, PLACL/SF/ZnO, PLACL/SF/ZnO/HAp, PLACL/SF/ZnO(HAp) biocomposite nanofibrous scaffolds.
Data's are presented as mean ± standard deviation with n=6 (*P≤0.05, **P≤ 0.01, ***P≤0.001).
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synthesis through a precipitation process, characterization and anti-
microbial activities of a nanohydroxyapatite/zinc oxide complex [40].
Other studies related to zinc incorporation into hydroxyapatite revealed
that zinc replaces calcium in hydroxyapatite structures [41] and as
depicted in Fig. 1. Zinc (Zn2+) is proven to stimulate the bone mineral
secretion in osteoblast cells [42]. Incorporation process of zinc and
hydroxyapatite can be simply explained as; isovalent Ca2+ in HAp is





Ca Zn 6PO 2OH Ca Zn (PO ) (OH) ; (0 x
10)












Chemical scheme: Local coordination of zinc in hydroxyapatite and
releasing the calcium ions.
Previous experiments showed Zn2+ doped HAp precipitated from
aqueous solution often showed number of Ca2+ vacancy. Later it was
described that Zn2+ incorporation into HAp does not occur by simple
replacement of ions but Ca2+ vacancy defect forms a plausible atomic
sites for substituting Zn2+ in HAp [43]. Most of the cases Zn2+ ions
prefers the Ca2+ site next to the hydroxyl column rather than Ca1 site
upon incorporation [41,43]. It should be noted that substitutional Zn2+
and the defect complex shows attractive interaction and energetically
favour the associated structure as shown in Fig. 1. Looking more closely
at the Fig. 1, shows that four oxygen atoms bonded to Zn, one from
nearest hydroxyl group and three from adjacent phosphate (PO4)
groups [44,45].
Fig. 6. CMFDA live cell imaging on biocomposite nanofibrous scaffolds on day 15. (a) TCP, (b) PLACL, (c) PLACL/ZnO, (d) PLACL/SF/ZnO, (e) PLACL/SF/ZnO/HAp,
(f) PLACL/SF/ZnO(HAp).
Fig. 7. Alkaline phosphatase (ALP) activity in hFOB cultured on TCP, PLACL, PLACL/ZnO, PLACL/SF/ZnO, PLACL/SF/ZnO/HAp, PLACL/SF/ZnO(HAp) bio-
composite nanofibrous scaffolds. Data's are presented as mean ± standard deviation with n=7(*P≤ 0.05, **P≤ 0.01, ***P≤ 0.001).
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3.2. Morphology of nanofibrous scaffolds
The nanofiber surface topography plays a crucial role in regulating
initial cell behaviour, such as cell adhesion, which can also influence
cell viability, proliferation and differentiation in later stages of cells.
SEM images reveal the fiber diameter reduced after addition of silk fi-
broin and HAp. Compared to PLACL and PLACL/ZnO fiber diameter
was larger slightly 715.4 ± 190 nm over 627.3 ± 103 nm. The ZnO
doped HAp fibers taking lead with a very small fiber diameter of
139.4 ± 27 nm with very slight standard deviation variations of
PLACL/SF/ZnO and PLACL/SF/ZnO(HAp) fibers with 192 ± 69 nm
and 139.4 ± 27 nm respectively (Fig. 2).
3.3. Wettability of the nanofibrous scaffolds
Hybrid scaffolds with natural polymers imparts functional groups
like amide, ester and hydroxyl groups making the scaffolds hydrophilic
to favour cell adhesion and proliferation [46]. Silk fibroin providing
amide groups which represents hydrophilic were as the other con-
stituents in the hydride scaffold like PLACL, ZnO particles lack this
ability which are in maximum percentage thus considering hydro-
phobic. The contact angle studies (Table 2) showed the fibrous scaffolds
was wetting the surface between 25 and 47° which comes under hy-
drophilic nature. All the scaffolds were hydrophobic later converted to
hydrophilic by the influence of plasma on their surface of the fibers.
During plasma treatment, the formation of polar bonds on the surface of
the nanofibrous scaffolds modifies the surface energy suitable for wet-
ting the surface thus results the samples to use for tissue engineering
applications.
3.4. Tensile properties of the nanofibers
Tissue engineering systems are highly dependent on the chemical
stability and mechanical properties of the scaffolds, which shows a huge
impact on cell proliferation and growth of the tissues. However HAp has
a major role in boosting the mineral secretion and low tensile strength,
brittleness hampers its application to the hard tissue implants [47,48].
Fig. 3/Table 3 shows the stress-strain curves for PLACL, PLACL/ZnO,
PLACL/SF/ZnO, PLACL/SF/ZnO/HAp and PLACL/SF/ZnO(HAp) bio-
composite nanofibrous scaffolds under normal room temperature. The
bonding of ZnO nanoparticles with PLACL fibers shows the maximum
elastic strain percentage 322.4% among other scaffolds and showing
second maximum ultimate stress at 2.25 ± 0.10MPa along with the
lead PLACL/SF/ZnO scaffolds with 2.56 ± 0.15MPa showing less
elastic strain percentage of 98.2%. The incorporation of silk fibroin
increases the yield strength by breaking the bondage between ZnO
particles with PLACL polymer showing a reduction in strain. The in-
terphase between the crystals, semicrystalline region and shear align-
ment of the molecular chain are the fundamental foundations for silk's
unique mechanical properties due to the combination of β-sheet crystals
[13]. The highly organized β-sheet regions of protein provide the high
tensile activity, tensile integrity, semicrystalline regions are the basis
for the proteins elastic nature [49]. Comparing PLACL/SF/ZnO/HAp
and PLACL/SF/ZnO(HAp) scaffolds both lack in tensile strength with
respect to the other fibers and showing elastic breaking percentage of
84.3% and 56.4% respectively. Within the ZnO and HAp fibers, the one
which has doped content shows the maximum yield strength
1.1 ± 0.20MPa by losing the strain with the other nanofibrous scaf-
folds.
3.5. Functional groups of fibrous scaffolds
The IR spectra of electrospun nanofibers PLACL, PLACL/ZnO,
PLACL/SF/ZnO, PLACL/SF/ZnO/HAp and PLACL/SF/ZnO(HAp) were
studied using Fourier transform infrared spectroscopy (Fig. 4). The
characteristics peaks were noted at 2951.08 and 1749.43 cm−1 re-
presenting nitrogen group (amine) (NeH Stretch) and C]O ketone,
CeH stretching at 3243.33 cm−1 for amide. The spectra of prepared
ZnO nanoparticles occurred in the range of 4000–400 cm−1 at room
temperature. The peak at 3463 cm−1 represents the presence of hy-
drogen bond OeH stretch and peaks at 2382.37 cm−1 represents the
CO2. The peaks 2862.36, 2922.59 and 2855.05 cm−1 represents the
CeH stretch on the nanofibrous scaffolds. Amide I, II and III are shown
at 1646.44, 1520.44 and 1269.02 cm−1. Stretching vibration of PO43−
from mineral HAp was obtained at 1087.85 and 1020.10 cm−1 for PeO
stretch at 589.14 cm−1 for PeO stretch coupled with PeO bend with
Fig. 8. SEM images of mineralization on the biocomposite nanofibrous scaffolds on day 15. (a) TCP, (b) PLACL, (c) PLACL/ZnO, (d) PLACL/SF/ZnO, (e) PLACL/SF/
ZnO/HAp, (f) PLACL/SF/ZnO(HAp).
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sharper peak for HAp nanofibers pertaining to 948.12 and
980.00 cm−1. Ca32− group from carbonate substituted OH and PO43−
group in HAp were obtained at about 1400–1480 cm−1 range
(Fig. 4d,e). Phosphate group 1000–1150 cm−1 indicates organic-in-
organic interaction between HAp crystals.
3.6. Proliferation of hFOB and live cell imaging
Biomimic ECM native environment for the scaffolds should be fa-
vourable for cell adhesion, proliferation and provides exchange of vital
nutrients to grow cells to promote the secretion of bone mineral matrix.
A huge number of cross-linked and rough surface nanofibrous scaffolds
support the proliferation of osteoblasts and faster regeneration process
of the defective bone. In addition to that suitable mechanical proper-
ties, hydrophilic nature, biomolecular signals from the nanofibers may
also guide cells entering the cell substrates by their amoeboid move-
ment [50]. The obtained results observed in Fig. 5, showing the cell
growth on day 5, there was increased cell proliferation on day 15 on the
progression of different fibrous scaffolds. It was found that the PLACL/
ZnO nanofibrous scaffolds showed less proliferation on comparing to
TCP from the beginning of the study on day 5 and later in day 10 in-
creased to 10%. Compared to PLACL with ZnO incorporated HAp
Fig. 9. A. Quantification of mineral deposits in hFOB by ARS staining on TCP, PLACL, PLACL/ZnO, PLACL/SF/ZnO, PLACL/SF/ZnO/HAp, PLACL/SF/ZnO(HAp)
biocomposite nanofibrous scaffolds. Data's are presented as mean ± standard deviation with n=10 (**P≤ 0.01, ***P≤0.001)
B. Alizarin Red staining for the mineralization of osteoblasts on day 15. (a) TCP, (b) PLACL, (c) PLACL/ZnO, (d) PLACL/SF/ZnO, (e) PLACL/SF/ZnO/HAp, (f) PLACL/
SF/ZnO(HAp) biocomposite nanofibrous scaffolds. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this
article.)
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nanofibrous scaffolds showed significantly (P≤ 0.001) increased on
day 15, which was 48% growth comparing ZnO/HAp scaffolds on the
same day with only 28% proliferation. The overall study, the highest
significant (P≤0.001) level of increase in cell growth by 98% in ZnO
incorporated HAp nanofibrous scaffolds, which proves the increased
mineral secretion as shown in ARS imaging in Fig. 9. Fluorescent
imaging is ventured on the cells seeded nanofibrous scaffolds under the
influence of 5-chloromethylfluorescein diacetate dye (CMFDA) shown
in Fig. 6. hFOB proliferated higher levels in ZnO and HAp doped na-
nofibrous scaffolds (Fig. 6e,f) compared to all other nanofibrous scaf-
folds. Whereas on PLACL/ZnO nanofibers (Fig. 6c) showing lesser cells
and abnormal cell morphology compared to PLACL/SF/ZnO/HAp
scaffolds.
3.7. ALP activity and mineralization of hFOB
ALP activity analysed for cells-scaffolds during the period of day 5,
10 and 15 showed in Fig. 7. ZnO(HAp) scaffolds observed significantly
increased ALP activity upto 44% on day 15 compared PLACL/ZnO fi-
bers on day 5. PLACL scaffolds with ZnO(HAp) composite on day 10
and 15 shows significantly (P≤0.01) increased activity by 28% and
35% respectively (Fig. 7). ALP activity directly related to the miner-
alization of ECM for forming bone minerals and nodules. The cell
density is observed confluent on day 15 of all nanofibrous scaffolds and
mineralization of the samples related to ZnO(HAp) doped samples
showing increased bone mineral formation (Fig. 8). Mineralization
phase begins with the secretion of mineral matrix upon undergoing
osteogenic differentiation. Feng et al. proved β-TCP scaffolds doped
with ZnO possessed good mechanical properties and excellent bio-
compatibility for bone tissue engineering [51]. HAp acts as a chelating
agent in PLACL/SF/ZnO/HAp and PLACL/SF/ZnO(HAp) scaffolds for
the mineralization of osteoblasts. Fig. 8f showing huge bone minerals
formation for proving that the PLACL/SF/ZnO(HAp) have good po-
tentiality for bone tissue regeneration. The higher concentration of ZnO
present in the fibers are not shown mineralization on day 15 compared
to ZnO(HAp) doped biocomposite nanofibrous scaffolds (Figs. 8, 9).
ZnO doped HAp biocomposite nanofibrous scaffolds showed 71%
growth progression for the secretion of minerals in Fig. 9a compared to
PLACL/ZnO. Mineralization was clearly observed on day 15 in PLACL/
SF/ZnO(HAp) scaffolds compared to PLACL and PLACL/ZnO fibers as
indicated in Fig. 9b related to the cell proliferation upto 49% as de-
scribed in Fig. 5. The presence of ZnO/SF/(HAp) in PLACL biocompo-
sites nanofibrous scaffolds proved increased cell proliferation, ALP ac-
tivity and mineralization for the obtained results, these biocomposite
material systems have proved the potentials for bone regenerative
therapy.
4. Conclusion
Harnessed a nanofiber that can mimic extracellular matrix by pro-
viding a suitable microenvironment that can help in greater miner-
alization of osteoblasts. The experimental results proved two factors
that ZnO/SF promotes the cell proliferation and ZnO incorporated/
doped HAp scaffolds trigger the cells for a higher level of bone minerals
secretion for the formation of bone. As stated above, these fabricated
scaffolds have increased mineralization but lack mechanical strength
due to the hydroxyapatite crystallinity. ZnO/SF incorporated/doped
hydroxyapatite in tissue engineering will provide a huge platform to
increase the studies on these metal oxide doped hydroxyapatite bio-
composites in further days for bone regenerative therapy.
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